|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial显示文摘 | Edward B Garon Tudor-Eliade Ciuleanu Oscar Arrieta Kumar Prabhash Konstantinos N Syrigos Tuncay Goksel Keunchil Park Vera Gorbunova Ruben Dario Kowalyszyn Joanna Pikiel Grzegorz Czyzewicz Sergey V Orlov Conrad R Lewanski Michael Thomas Paolo Bidoli Shaker | 2014 | The Lancet2014，，： | 2 |
| 2 | CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: potential predictor of early engraftment 显示文摘 | Prabhash K Khattry N Bakshi A | 2010 | Ann Oncol2010，21，3： | 1 |
| 3 | Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia显示文摘 | Prabhash K Biswas G Prasad N | 2006 | Indi- an J Dermatol Venereol Leprol2006，72，： | 1 |
| 4 | A randomized, double-blind, phase m trial of ramucirumab, a VEGFR-2 monoclonal antibody, plus Docetaxel versus placebo plus Docetaxel for second-line treatment of non-small cell lung cancer 显示文摘 | Ciuleanu TE Arrieta O Prabhash K | 2014 | J Clin Oucol2014，32，15： | 1 |
| 5 | EGFR muta-tions in indian lung cancer patients : clinical correlation andoutcome to EGFR targeted therapy显示文摘 | Noronha V Prabhash K Thavamani A | 2013 | PLoS One2013，8，61： | 1 |
| 6 | Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattem显示文摘 | Prabhash K Medhekar A Ghadyalpatil N | 2010 | Indian J Cancer2010，47，2： | 1 |
| 7 | Cultural, morphological, pathogenic and molecular variability amongst tomato isolates of Alternaria solani in India显示文摘 | Virendra Kumar Sanchita Haldar Koshlendra K. Pandey Rana P. Singh Achuit K. Singh Prabhash C. Singh | 2008 | World Journal of Microbiology and Biotechnology2008，，7： | 1 |
| 8 | Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia显示文摘 | S Polampalli A Choughule K Prabhash P Amare C Baisane S Kabre S Mahadik S Shinde R Nair S Banavali | 2011 | Indian Journal of Cancer2011，，1： | 1 |
| 9 | Gastrointestinal stromal tumour-a paradigm shift in management of solid tumors显示文摘 | Bapsy PP Prabhash K Babu KG | 2003 | JAPI2003，51，8： | 1 |
| 10 | Fine-tuning control on CNT diameter distribution, length and density using thermal CVD growth at atmospheric pressure: an in-depth analysis on the role of flow rate and flow duration of acetylene (C 2 H 2 ) gas显示文摘 | Nishant Tripathi Prabhash Mishra Harsh Harsh S. S. Islam | 2015 | Applied Nanoscience2015，，1： | 1 |
| 11 | Role of RT-PCRand FISH in diagnosis and monitoring of acute promyelocytic leukemia显示文摘 | Polampalli S Choughule A Prabhash K | 2011 | Indian J Cancer2011，48，1： | 1 |
| 12 | Nimotttzumab plus chemotherapy versus chemotherapy alone in advanced non-small-ceU lung cancer: a multicenter, randomized, open-label Phase 1I study显示文摘 | Babu K G Prabhash K Vaid A K | 2014 | Onco Targets Tber2014，7，2： | 1 |
| 13 | Side effects and efficacy of thalidomide and low dose dexamethasone combination in newly diagnosed symptomatic myeloma patients in India-A pilot study显示文摘 | Jain P Pai VR Prabhash K | 2008 | Journal of Clinical Oncology2008，26，19： | 1 |
| 14 | A year of anaplastic large cell kinase testing for lung carcinoma: pathological and technical perspectives显示文摘 | Desai S S Shah A S Prabhash K | 2013 | Indian J Cancer2013，50，2： | 1 |
| 15 | Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxanebased induction chemotherapy and concurrent chemo-radiotherapy in the modern era显示文摘Objective:To evaluate the survival outcomes for a cohort of nasopharyngeal cancer with intracranial extension(ICE)treated with induction chemotherapy(ICT)followed by chemo-intensity-modulated radiotherapy(CTRT)at a tertiary cancer center.Methods:We retrospectively analyzed 45 patients with histologically proven,non-metastatic NPC with ICE treated at our institute between October 2008 and October 2016.Patients were classified as minor ICE or major ICE,based on the extent of ICE.All the patients received 2-3 cycles of a taxane-based ICT regimen followed by CTRT.Radiotherapy was delivered with'riskadapted'intensity-modulated radiotherapy(IMRT)technique in all patients.Results:After a median follow up of 45 months(range:8-113 months),the estimated 5-year DFS,LRFS,DMFS,and OS of the entire cohort was 58%,82%,67%and 74%respectively.On multivariate analysis,histological subtype was an independent predictor of LRFS,and age was an independent predictor of DFS.The extent of ICE showed only a trend towards worse DFS(P=0.06).None of the factors significantly predicted for DMFS or OS.Gender,N-stage,and response to ICT did not significantly affect any of the outcomes.Grade 2 or worse subcutaneous fibrosis was seen in 22%of patients and grade 2 or worse xerostomia was seen in 24%of patients at last follow up.Thirty-three percent of the patients developed clinical hypothyroidism at last follow up.None of the patients experienced any neurological or vascular complications.Conclusions:Taxane-based induction chemotherapy followed by chemo-intensity modulated radiotherapy resulted in excellent locoregional control and survival with acceptable toxicities in patients of nasopharyngeal cancer with intracranial extension.Distant metastasis continues to be the predominant problem in these patients. | Sarbani Ghosh-Laskar Avinash Pilar Carlton Johnny Kumar Prabhash Amit Joshi Jai Prakash Agarwal Tejpal Gupta Ashwini Budrukkar Vedang Murthy Monali Swain Vanita Noronha Vijay Maruthi Patil Prathamesh Pai Deepa Nair Devendra Arvind Chaukar Shivakumar Thiagarajan Gouri Pantvaidya Anuja Deshmukh Pankaj Chaturvedi Sudhir Nair Anil D’Cruz | 2020 | World Journal of Otorhinolaryngology-Head and Neck Surgery2020，6，1： | 1 |
| 16 | EGFR Mutations in in- dian lung cancer patients: clinical correlation and outcome to EGFR targeted therapy 显示文摘 | Noronha V Prabhash K Thavamani A | 2013 | PLoS One2013，8，61： | 1 |
| 17 | Neuroendocrine carcinoma of gallbladder: report of 2 cases显示文摘BACKGROUND: Neuroendocrine carcinoma of the gall- bladder is rare. Its best treatment is not known. METHODS: Two patients underwent surgery earlier: one for suspected cholecystitis and the other for cholelithiasis. Magnetic resonance cholangiopancreatography ( MRCP ) showed residual lesions in the livers. The two patients un- derwent revision surgery followed by chemotherapy. RESULTS; Both patients tolerated the second stage surgery well, which was followed by chemotherapy with paclitaxel, ifosphamide and cisplatin for 6 cycles. They were treated this way for 8 months and 12 months post treatment, re- spectively. CONCLUSIONS: A proper diagnosis of neuroendocrine carcinoma is made often after surgery. As it is a slow grow- ing tumor and not very chemotherapeutically, sensitive sur- gery offers the best local control. | Keechilat Pavithran Kumar Prabhash Diganta Hazarika Dinesh C Doval | 2005 | Hepatobiliary & Pancreatic Diseases International2005，4，1： | 1 |
| 18 | Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non- small-cell lung cancer: a multicenter, randomized, open-la- bel Phase Ⅱ study显示文摘 | Babu KG Prabhash K Vaid AK | 2014 | Onco Targets Ther2014，7，： | 1 |
| 19 | Deletion of 6q23 as sole abnormality in acute myelocytic leukemia 显示文摘 | Sundareshan TS Prabhash K Bapsy PP | 2003 | Cancer Genet Cytogenet2003，143，1： | 1 |
| 20 | Crizotinib : A comprehensivereview显示文摘 | Sahu A Prabhash K Noionha V f | 2013 | Dig South Asian J Cancer2013，2，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员